Internal Medicine, Hematology & Oncology · Lakewood, CA
NPI
1861463606
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3650 South St, 212
Lakewood, CA, 90712
Phone (562) 272-7630
Groups this clinician bills Medicare through
Medicare paid, 2024
$819K
30,568 services
Medicare patients, 2024
394
Average age 74
Drug cost, 2024
$5.3M
898 prescriptions
Company payments, 2025
$4,850
From 51 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Raghu Nandan was code J0897 (injection, denosumab, 1 mg), 4,204 times for 12 patients. In total Raghu Nandan billed 30,568 services in 71 codes, and Medicare paid $819K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 4,204 | 12 | $20.62 | $87K |
| 99233 Hospital E&M - Subsequent | Facility | 1,372 | 162 | $97.47 | $134K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,028 | 16 | $0.09 | $94.17 |
| 99214 Office E&M - Established | Office | 817 | 208 | $100.34 | $82K |
| 99232 Hospital E&M - Subsequent | Facility | 781 | 129 | $65.05 | $51K |
| 85025 Blood Count | Office | 660 | 140 | $7.61 | $5,023 |
| 36415 Venipuncture Blood Collection | Office | 567 | 131 | $8.63 | $4,894 |
| 96127 Behavioral Health Services | Office | 377 | 186 | $3.64 | $1,371 |
| 96372 Injection Administration | Office | 212 | 29 | $12.23 | $2,592 |
| 99223 Hospital E&M - Initial | Facility | 168 | 155 | $141.37 | $24K |
| 96413 Chemotherapy Administration | Office | 91 | 14 | $111.09 | $10K |
| 99215 Office E&M - Established | Office | 76 | 50 | $143.26 | $11K |
| 96367 Intravenous Infusion, Hydration | Office | 74 | 17 | $23.02 | $1,704 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 60 | 16 | $0.63 | $37.83 |
| 99205 Office E&M - New | Office | 44 | 44 | $172.03 | $7,569 |
By year: 2022 $504K for 32,926 services; 2023 $941K for 27,303 services; 2024 $819K for 30,568 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 660 | 140 | $7.61 | $5,023 |
| 36415 Venipuncture Blood Collection | 567 | 131 | $8.63 | $4,894 |
Medicare prescription drug claims, 2024
In 2024, the drug Raghu Nandan prescribed most often to Medicare patients was Anastrozole, with 56 prescriptions and refills. In total Raghu Nandan wrote 898 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 56 | 121 | 15 | $676 |
| Revlimid Lenalidomide | 55 | 55 | Under 11 | $925K |
| Ondansetron Odt Ondansetron | 44 | 46 | 32 | $923 |
| Procrit Epoetin Alfa | 35 | 35 | 11 | $100K |
| Nubeqa Darolutamide | 34 | 42 | Under 11 | $410K |
| Eliquis Apixaban | 30 | 38 | Under 11 | $20K |
| Dexamethasone Generic | 29 | 41 | 11 | $523 |
| Tagrisso Osimertinib Mesylate | 27 | 27 | Under 11 | $413K |
| Prednisone Generic | 21 | 30 | Under 11 | $101 |
| Famciclovir Generic | 18 | 28 | Under 11 | $1,001 |
| Olanzapine Generic | 18 | 22 | Under 11 | $113 |
| Potassium Chloride Generic | 16 | 16 | Under 11 | $203 |
| Dexamethasone Sodium Phosphate Generic | 15 | 15 | Under 11 | $96.08 |
| Lupron Depot Leuprolide Acetate | 15 | 41 | Under 11 | $82K |
| Zarxio Filgrastim-Sndz | 15 | 15 | Under 11 | $17K |
Brand drugs: 466 claims; generic drugs: 432 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Raghu Nandan $4,850 ($4,850 in general payments such as food, travel and fees) from 51 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,440.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 20 | $1,440 |
| Pfizer Inc. PFE | 17 | $344 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $192 |
| Janssen Biotech, Inc. JNJ | 7 | $191 |
| Genzyme Corporation SNY | 6 | $188 |
| Daiichi Sankyo Inc. 4568.T | 9 | $185 |
| Incyte Corporation INCY | 6 | $154 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $146 |
| Puma Biotechnology, Inc. PBYI | 6 | $141 |
| Lilly USA, LLC LLY | 5 | $141 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.